Pyrimidine-Based Tricyclic Molecules as Potent and Orally Efficacious Inhibitors of Wee1 Kinase

被引：20

作者：

Tong, Yunsong ^{[1
]}

Torrent, Maricel ^{[2
]}

Florjancic, Alan S. ^{[1
]}

Bromberg, Kenneth D. ^{[1
]}

Buchanan, Fritz G. ^{[1
]}

Ferguson, Debra C. ^{[1
]}

Johnson, Eric F. ^{[1
]}

Lasko, Loren M. ^{[1
]}

Maag, David ^{[1
]}

Merta, Philip J. ^{[4
]}

Olson, Amanda M. ^{[3
]}

Osterling, Donald J. ^{[3
]}

Soni, Nirupama ^{[1
]}

Shoemaker, Alexander R. ^{[1
]}

Penning, Thomas D. ^{[1
]}

机构：

[1] AbbVie, Canc Res, N Chicago, IL 60064 USA

[2] AbbVie, Mol Modeling, N Chicago, IL 60064 USA

[3] AbbVie, Pharmacol, N Chicago, IL 60064 USA

[4] AbbVie, Res & Dev, High Throughput Biol, N Chicago, IL 60064 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 01期

关键词：

Wee1 kinase inhibitors; antitumor; CHECKPOINT KINASE; MITOTIC CATASTROPHE; TYROSINE KINASE; GENE-EXPRESSION; CANCER-THERAPY; CDK1;

D O I：

10.1021/ml5002745

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Aided by molecular modeling, compounds with a pyrimidine-based tricyclic scaffold were designed and confirmed to inhibit Wee1 kinase. Structure-activity studies identified key pharmacophores at the aminoaryl and halo-benzene regions responsible for binding affinity with sub-nM Ki values. The potent inhibitors demonstrated sub-mu M activities in both functional and mechanism-based cellular assays and also possessed desirable pharmacokinetic profiles. The lead molecule, 31, showed oral efficacy in potentiating the antiproliferative activity of irinotecan, a cytotoxic agent, in a NCI-H1299 mouse xenograft model.

引用

页码：58 / 62

页数：5

共 50 条

[1] Discovery of pyrrolo[2,3-d]pyrimidine-based molecules as a Wee1 inhibitor template
Chen, Changjun
Wang, Yeliu
Hu, Min-Qi
Li, Hongjuan
Chen, Xi
Qiang, Gan
Sun, Yinghui
Zhu, Yan
Li, Binghui
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 75
[2] Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds
Abdullah, Maaged
Guruprasad, Lalitha
STRUCTURAL CHEMISTRY, 2019, 30 (01) : 213 - 226
[3] Computational fragment-based design of Wee1 kinase inhibitors with tricyclic core scaffolds
Maaged Abdullah
Lalitha Guruprasad
Structural Chemistry, 2019, 30 : 213 - 226
[4] Development of novel, potent orally available Wee1 inhibitors with robust antitumor efficacy in vivo
Gavory, Gerald
O'Dowd, Colin
Rozycka, Ewelina
Boyd, Caroline
Gorges, Beronia
McLean, Estelle
Rountree, Shane
Sheperd, Steven
Burton, Stephanie
McFarland, Mary
Janssen, Dominic
Treder, Adam
Wilkinson, Andy
Burkamp, Frank
Harrison, Tim
MOLECULAR CANCER RESEARCH, 2017, 15
[5] Investigation of biaryl heterocycles as inhibitors of Wee1 kinase
Mastracchio, Anthony
Lai, Chunqiu
Torrent, Maricel
Bromberg, Kenneth
Buchanan, Fritz G.
Ferguson, Debra
Bontcheva, Velitchka
Johnson, Eric F.
Lasko, Loren
Maag, David
Soni, Nirupama
Shoemaker, Alexander R.
Penning, Thomas D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (12) : 1481 - 1486
[6] Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3
Chen, Jack J.
Thakur, Kumar D.
Clark, Michael P.
Laughlin, Steven K.
George, Kelly M.
Bookland, Roger G.
Davis, Jan R.
Cabrera, Edward J.
Easwaran, Vijay
De, Biswanath
Zhang, Y. George
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5633 - 5638
[7] Potent and Orally Efficacious Bisthiazole-Based Histone Deacetylase Inhibitors
Chen, Fei
Chai, Hui
Su, Ming-Bo
Zhang, Yang-Ming
Li, Jia
Xie, Xin
Nan, Fa-Jun
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (06): : 628 - 633
[8] Potent, selective and orally efficacious inhibitors of Plasmodium falciparum protein kinase G (PfPKG)
Harding, Denise
Osborne, Simon
Birchall, Kristian
Bouloc, Nathalie
Large, Jonathan
Merritt, Andy
Smiljanic-Hurley, Ela
Wheldon, Mary
Ansell, Keith
Kettleborough, Catherine
Whalley, David
Bowyer, Paul
Stewart, Lindsay
Baker, David
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[9] Discovery of potent and orally active tricyclic-based FBPase inhibitors
Tsukada, Tomoharu
Kanno, Osamu
Yamane, Takahiro
Tanaka, Jun
Yoshida, Taishi
Okuno, Akira
Shiiki, Takeshi
Takahashi, Mizuki
Nishi, Takahide
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5346 - 5351
[10] Ensemble docking-based virtual screening toward identifying inhibitors against Wee1 kinase
Li, Yaping
Wu, Dong-mei
Kong, Ling-mei
Zhang, Shuqun
Du, Haibo
Sun, Wei
Zhang, Li
Li, Yan
Zuo, Zhili
FUTURE MEDICINAL CHEMISTRY, 2019, 11 (15) : 1889 - 1906

← 1 2 3 4 5 →